HOPKINTON, Mass., Nov. 3, 2010 /PRNewswire-FirstCall/ -- Caliper Life Sciences, Inc. (Nasdaq: CALP), a leading provider of tools and services for drug discovery and life sciences research, today announced a collaboration with Sony DADC Austria AG for the co-development and manufacture of plastic consumables for Caliper's next generation microfluidics products. The agreement combines Sony DADC's premier Blu-ray Disc™ manufacturing technology and manufacturing capacity with Caliper's extensive microfluidics expertise and patent portfolio to develop enabling solutions for life science researchers and for diagnostic applications.
Caliper Life Sciences and Sony DADC have co-developed consumables for the LabChip® XT system, Caliper's automated nucleic acid fractionation instrument for next generation sequencing applications. The LabChip XT removes a key bottleneck in sequencing workflows by replacing tedious gel isolation and purification steps used in size selection. The plastic chips manufactured by Sony DADC allow Caliper to offer a cost-effective and disposable consumable that eliminates cross-contamination potential, which is of key concern for genomics researchers.
"The exacting requirements for fragment size control in Next Gen Sequencing are best addressed with Caliper's patented microfluidics technology, while the scale of the opportunity created an opportunity for outsourced manufacturing and the transition to plastic chip format," said Kevin Hrusovsky, President and CEO of Caliper Life Sciences. "We selected Sony DADC, the world's largest producer of super high quality Blu-ray discs, because of their outstanding quality and large volume manufacturing credentials."
"Sony DADC is pleased to partner with Caliper Life Sciences to co-develop breakthrough microfluidic technologies based on our high volume plastic consumable manufacturing capabil